Temporal induction of clusterin in the peri-infarct zone after experimental myocardial infarction in the rat

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 1, 1998, Pages 28-35

  Silkensen, John R ^a   Hirsch, Alan T ^a   Lunzer, Mary M ^a   Chmielewski, David ^a   Manivel, J Carlos ^a   Muellerleile, Michael R ^a   Rosenberg, Mark E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031933525     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90074-9     Document Type: Article

References (30)

1. Fritz IB, Murphy B. Clusterin. Insights into a multifunctional protein. Trends Endocrinol Metab 1993;4:41-5.
2. Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biol Sci 1992;17:154-9.
3. Rosenberg ME, Dvergsten J, Correa-Rotter R. Clusterin: an enigmatic protein recruited by diverse stimuli. J Lab Clin Med 1993;121:205-14.
4. Rosenberg ME, Silkensen JR. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-45.
5. Witte DP, Aronow BJ, Dry JK, Harmony JAK. Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis. Dev Dyn 1994;201:290-6.
6. Swertfeger DK, Witte DP, Stuart WD, Rockman HA, Harmony JA. Apolipoprotein J/clusterin induction in myocarditis: a localized response gene to myocardial injury. Am J Pathol 1996;148:1971-83.
7. Väkevä A, Laurila P, Meri S. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology 1993;80:177-82.
8. Correa-Rotter R, Hostetter TH, Manivel JC, Eddy AA, Rosenberg ME. Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int 1992;41:938-50.
9. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69:475-82.
10. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
11. Correa-Rotter R, Hostetter TH, Nath KA, Manivel JC, Rosenberg ME. Interaction of complement and cluslerin in renal injury. J Am Soc Nephrol 1992;3:1172-9.
12. Collard MW, Griswold MD. Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 1987;26:3297-303.
13. Nath KA, Dvergsten J, Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME. Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest 1994;71:209-18.
14. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, et al. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 1989;35:60-8.
15. Wong P, Pineault J, Lakins J, Taillefer D, Léger J, Wang C, et al. Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 1993;268:5021-31.
16. Crawford MH, Grover FL, Kolb WP, McMahan CA, O'Rourke RA, McManus LM, et al. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988;78:1449-58.
17. McManus L, Kolb W, Crawford M, O'Rourke R, Grover F, Pinckard R. Complement localization in ischemic baboon myocardium. Lab Invest 1983;48:436-47.
18. Maroko PR, Carpenter CB, Chariello M, Fishbein MC, Radvany P, Knostman JD, et al. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 1978;61:661-70.
19. MacLean D, Fishbein MC, Braunwald E, Maroko PR. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. J Clin Invest 1978;61:541-51.
20. Weisman H, Bartow T, Leppo M, Marsh H, Carson G, Concino M, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1988;249:146-51.
21. Choi N-H, Mazda T, Tomita M. A serum protein SP40, 40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol Immunol 1989;26:835-40.
22. Saunders JR, Aminian A, McRae JL, O'Farrell KA, Adam WR, Murphy BF. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 1994;45:817-27.
23. Loomis P, Jeff-Jackson CE. Plastic studies in abnormal architecture. VI. An investigation of the circulation of infarcts in the kidney. Arch Pathol 1942;33:735-69.
24. DeSilva HV, Stuart WD, Park YB, Mao SJT, Gil CM, Wetterau JR, et al. Purification and characterization of apolipoprotein J. J Biol Chem 1990;265:14292-7.
25. Aronow BJ, Lund DS, Brown TL, Harmony JAK, Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci 1993; 90:725-9.
26. Silkensen JR, Skubitz KM, Skubitz APN, Chmielewski DH, Manivel JC, Dvergsten JA, et al. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J Clin Invest 1995;96:2646-53.
27. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 1988;78:186-201.
28. Vaughan DE, Pfeffer MA. Post-myocardial infarction ventricular remodeling: animal and human studies. Cardiovasc Drugs Ther 1994;8:453-60.
29. Bogen DK, Rabinowitz SA, Needleman A, McMahon TA, Abelmann WH. An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle. Circ Res 1980;47:728-41. ;
30. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year following first anterior myocardial infarction: a quantitative analysis of alteration in contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992;19:1136-44.